Hyperoxaluria Clinical Trial
Official title:
Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk
The purpose of this study is to ascertain whether certain supplements promote excessive urinary oxalate excretion and increase the risk for calcium oxalate kidney stones. Supplements that enhance urinary oxalate excretion, as a result of their oxalate concentration or from some other mechanism (e.g., providing substrate for oxalate biosynthesis) will be identified by the investigators.
The investigators hypothesize that certain over-the-counter dietary supplements will increase urinary excretion of oxalate as measured in 24-h urine collections. The investigators further hypothesize that the concentration of oxalate in dietary supplements may not be associated with urinary oxalate excretion, suggesting that other nutritional components of the supplements may be exerting an influence over oxalate biosynthesis, oxalate absorption in the gastrointestinal tract, and/or renal oxalate handling. These other factors include the form of oxalate in the supplement (water- vs. non water-soluble) and the supplement's concentration of ascorbic acid. ;
Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06138327 -
A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria
|
Phase 1 | |
Completed |
NCT02547805 -
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
|
Phase 2 | |
Completed |
NCT02289755 -
Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
|
Phase 2 | |
Completed |
NCT02038543 -
Hydroxyproline Influence on Oxalate Metabolism
|
Phase 1/Phase 2 | |
Completed |
NCT03095885 -
A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
|
N/A | |
Recruiting |
NCT02780297 -
Prospective Research Rare Kidney Stones (ProRKS)
|
||
Completed |
NCT01127087 -
Oxazyme in Patients With Hyperoxaluria
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05443932 -
Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients
|
Phase 4 | |
Completed |
NCT04756024 -
Reference Interval of Spot Urinary Oxalate to Creatinine Ratio in Children
|
||
Completed |
NCT02503345 -
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones
|
Phase 2 | |
Completed |
NCT00199459 -
Proteomic Study of Urinary Stone Disease
|
N/A | |
Completed |
NCT04119765 -
Plasma Oxalate in Patient With Short Bowel
|
||
Completed |
NCT00283387 -
Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria
|
Phase 2 | |
Completed |
NCT00587041 -
Use of Oral Probiotics to Reduce Urinary Oxalate Excretion
|
Phase 1/Phase 2 | |
Completed |
NCT04571359 -
Spot Urine Oxalate to Creatinine Ratio and 24 Hours Urinary Oxalate
|
||
Withdrawn |
NCT00280215 -
Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
|
Phase 3 | |
Completed |
NCT00588120 -
Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
|
Phase 1 |